Integrated proteomic, transcriptomic, and biological network analysis of breast carcinoma reveals molecular features of tumorigenesis and clinical relapse

Molecular and Cellular Proteomics

Volumn 11, Issue 6, 2012, Pages

  Imielinsk, Marcin ^a   Cha, Sangwon ^b   Rejtar, Tomas ^b   Richardson, Elizabeth A ^a   Karger, Barry L ^b   Sgroi, Dennis C ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NORTHEASTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE P38; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; PROTEOME;

ADULT; AGED; ARTICLE; BREAST CARCINOGENESIS; BREAST CARCINOMA; CANCER RELAPSE; CELL STRESS; CLINICAL ARTICLE; ESTROGEN RECEPTOR POSITIVE BREAST CANCER; GENE EXPRESSION; HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; TRANSCRIPTOMICS; TUMOR MICROENVIRONMENT; ADOLESCENT; BREAST TUMOR; CASE CONTROL STUDY; CELL TRANSFORMATION; EPITHELIUM; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETICS; KAPLAN MEIER METHOD; LASER CAPTURE MICRODISSECTION; METABOLISM; MIDDLE AGED; MORTALITY; PAGET NIPPLE DISEASE; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; PROTEIN PROTEIN INTERACTION; RECEIVER OPERATING CHARACTERISTIC; TUMOR RECURRENCE;

ADOLESCENT; ADULT; AGED; BREAST NEOPLASMS; CARCINOMA, DUCTAL; CASE-CONTROL STUDIES; CELL TRANSFORMATION, NEOPLASTIC; EPITHELIUM; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; HUMANS; KAPLAN-MEIER ESTIMATE; LASER CAPTURE MICRODISSECTION; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROPORTIONAL HAZARDS MODELS; PROTEIN INTERACTION MAPS; PROTEOME; PROTEOMICS; ROC CURVE; YOUNG ADULT;

EID: 84862333922     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M111.014910     Document Type: Article

References (73)

1. Bièche, I., and Lidereau, R. (2011) Genome-based and transcriptome-based molecular classification of breast cancer. Curr. Opin. Oncol. 23, 93-99
2. Bombonati, A., and Sgroi, D. C. (2011) The molecular pathology of breast cancer progression. J. Pathol. 223, 307-317
3. Zhang, X. H., Wang, Q., Gerald, W., Hudis, C. A., Norton, L., Smid, M., Foekens, J. A., and Massagué, J. (2009) Latent bone metastasis in breast cancer tied to Src-dependent survival signals. Cancer Cell 16, 67-78
4. Easton, D. F., Pooley, K. A., Dunning, A. M., Pharoah, P. D., Thompson, D., Ballinger, D. G., Struewing, J. P., Morrison, J., Field, H., Luben, R., Wareham, N., Ahmed, S., Healey, C. S., Bowman, R., Meyer, K. B., Haiman, C. A., Kolonel, L. K., Henderson, B. E., Le Marchand, L., Brennan, P., Sangrajrang, S., Gaborieau, V., Odefrey, F., Shen, C. Y., Wu, P. E., Wang, H. C., Eccles, D., Evans, D. G., Peto, J., Fletcher, O., Johnson, N., Seal, S., Stratton, M. R., Rahman, N., Chenevix-Trench, G., Bojesen, S. E., Nordestgaard, B. G., Axelsson, C. K., Garcia-Closas, M., Brinton, L., Chanock, S., Lissowska, J., Peplonska, B., Nevanlinna, H., Fagerholm, R., Eerola, H., Kang, D., Yoo, K. Y., Noh, D. Y., Ahn, S. H., Hunter, D. J., Hankinson, S. E., Cox, D. G., Hall, P., Wedren, S., Liu, J., Low, Y. L., Bogdanova, N., Schürmann, P., Dörk, T., Tollenaar, R. A., Jacobi, C. E., Devilee, P., Klijn, J. G., Sigurdson, A. J., Doody, M. M., Alexander, B. H., Zhang, J., Cox, A., Brock, I. W., MacPherson, G., Reed, M. W., Couch, F. J., Goode, E. L., Olson, J. E., Meijers-Heijboer, H., van, den, Ouweland, A., Uitterlinden, A., Rivadeneira, F., Milne, R. L., Ribas, G., Gonzalez-Neira, A., Benitez, J., Hopper, J. L., McCredie, M., Southey, M., Giles, G. G., Schroen, C., Justenhoven, C., Brauch, H., Hamann, U., Ko, Y. D., Spurdle, A. B., Beesley, J., Chen, X., Mannermaa, A., Kosma, V. M., Kataja, V., Hartikainen, J., Day, N. E., Cox, D. R., and Ponder, B. A. (2007) Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 447, 1087-1093 (Pubitemid 47014426)
5. Horlings, H. M., Lai, C., Nuyten, D. S., Halfwerk, H., Kristel, P., van Beers, E., Joosse, S. A., Klijn, C., Nederlof, P. M., Reinders, M. J., Wessels, L. F., and van de Vijver, M. J. (2010) Integration of DNA copy number alterations and prognostic gene expression signatures in breast cancer patients. Clin. Cancer Res. 16, 651-663
6. Navin, N., Kendall, J., Troge, J., Andrews, P., Rodgers, L., McIndoo, J., Cook, K., Stepansky, A., Levy, D., Esposito, D., Muthuswamy, L., Krasnitz, A., McCombie, W. R., Hicks, J., and Wigler, M. (2011) Tumour evolution inferred by single-cell sequencing. Nature 472, 90-94
7. Shah, S. P., Morin, R. D., Khattra, J., Prentice, L., Pugh, T., Burleigh, A., Delaney, A., Gelmon, K., Guliany, R., Senz, J., Steidl, C., Holt, R. A., Jones, S., Sun, M., Leung, G., Moore, R., Severson, T., Taylor, G. A., Teschendorff, A. E., Tse, K., Turashvili, G., Varhol, R., Warren, R. L., Watson, P., Zhao, Y., Caldas, C., Huntsman, D., Hirst, M., Marra, M. A., and Aparicio, S. (2009) Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution. Nature 461, 809-813
8. Ding, L., Ellis, M. J., Li, S., Larson, D. E., Chen, K., Wallis, J. W., Harris, C. C., McLellan, M. D., Fulton, R. S., Fulton, L. L., Abbott, R. M., Hoog, J., Dooling, D. J., Koboldt, D. C., Schmidt, H., Kalicki, J., Zhang, Q., Chen, L., Lin, L., Wendl, M. C., McMichael, J. F., Magrini, V. J., Cook, L., McGrath, S. D., Vickery, T. L., Appelbaum, E., Deschryver, K., Davies, S., Guintoli, T., Lin, L., Crowder, R., Tao, Y., Snider, J. E., Smith, S. M., Dukes, A. F., Sanderson, G. E., Pohl, C. S., Delehaunty, K. D., Fronick, C. C., Pape, K. A., Reed, J. S., Robinson, J. S., Hodges, J. S., Schierding, W., Dees, N. D., Shen, D., Locke, D. P., Wiechert, M. E., Eldred, J. M., Peck, J. B., Oberkfell, B. J., Lolofie, J. T., Du, F., Hawkins, A. E., O'Laughlin, M. D., Bernard, K. E., Cunningham, M., Elliott, G., Mason, M. D., Thompson, D. M., Jr, Ivanovich, J. L., Goodfellow, P. J., Perou, C. M., Weinstock, G. M., Aft, R., Watson, M., Ley, T. J., Wilson, R. K., and Mardis, E. R. (2010) Genome remodelling in a basal-like breast cancer metastasis and xenograft. Nature 464, 999-1005
9. Sanders, M. E., Dias, E. C., Xu, B. J., Mobley, J. A., Billheimer, D., Roder, H., Grigorieva, J., Dowsett, M., Arteaga, C. L., and Caprioli, R. M. (2008) Differentiating proteomic biomarkers in breast cancer by laser capture microdissection and MALDI MS. J. Proteome Res. 7, 1500-1507
10. Johann, D. J., Rodriguez-Canales, J., Mukherjee, S., Prieto, D. A., Hanson, J. C., Emmert-Buck, M., and Blonder, J. (2009) Approaching solid tumor heterogeneity on a cellular basis by tissue proteomics using laser capture microdissection and biological mass spectrometry. J. Proteome Res. 8, 2310-2318
11. Schulz, D. M., Böllner, C., Thomas, G., Atkinson, M., Esposito, I., Höfler, H., and Aubele, M. (2009) Identification of differentially expressed proteins in triple-negative breast carcinomas using DIGE and mass spectrometry. J. Proteome Res. 8, 3430-3438
12. Weitzel, L. R., Byers, T., Allen, J., Finlayson, C., Helmke, S. M., Hokanson, J. E., Hunsucker, S. W., Murphy, J. R., Newell, K., Queensland, K. M., Singh, M., Wischmeyer, P. E., Duncan, M. W., and Elias, A. (2010) Discovery and verification of protein differences between Er positive/Her2/neu negative breast tumor tissue and matched adjacent normal breast tissue. Breast Cancer Res. Treat. 124, 297-305
13. Bauer, J. A., Chakravarthy, A. B., Rosenbluth, J. M., Mi, D., Seeley, E. H., De Matos Granja-Ingram, N., Olivares, M. G., Kelley, M. C., Mayer, I. A., Meszoely, I. M., Means-Powell, J. A., Johnson, K. N., Tsai, C. J., Ayers, G. D., Sanders, M. E., Schneider, R. J., Formenti, S. C., Caprioli, R. M., and Pietenpol, J. A. (2010) Identification of markers of taxane sensitivity using proteomic and genomic analyses of breast tumors from patients receiving neoadjuvant paclitaxel and radiation. Clin. Cancer Res. 16, 681-690
14. Cha, S., Imielinski, M. B., Rejtar, T., Richardson, E. A., Thakur, D., Sgroi, D. C., and Karger, B. L. (2010) In situ proteomic analysis of human breast cancer epithelial cells using laser capture microdissection: Annotation by protein set enrichment analysis and gene ontology. Mol. Cell. Proteomics 9, 2529-2544
15. Kang, S., Kim, M. J., An, H., Kim, B. G., Choi, Y. P., Kang, K. S., Gao, M. Q., Park, H., Na, H. J., Kim, H. K., Yun, H. R., Kim, D. S., and Cho, N. H. (2010) Proteomic molecular portrait of interface zone in breast cancer. J. Proteome Res. 9, 5638-5645
16. Bateman, N. W., Sun, M., Bhargava, R., Hood, B. L., Darfler, M. M., Kovatich, A. J., Hooke, J. A., Krizman, D. B., and Conrads, T. P. (2011) Differential proteomic analysis of late-stage and recurrent breast cancer from formalin-fixed paraffin-embedded tissues. J. Proteome Res. 10, 1323-1332
17. Harrell, J. C., Dye, W. W., Harvell, D. M., Sartorius, C. A., and Horwitz, K. B. (2008) Contaminating cells alter gene signatures in whole organ versus laser capture microdissected tumors: A comparison of experimental breast cancers and their lymph node metastases. Clin. Exp. Metastasis 25, 81-88 (Pubitemid 351191228)
18. Fuller, A. P., Palmer-Toy, D., Erlander, M. G., and Sgroi, D. C. (2003) Laser capture microdissection and advanced molecular analysis of human breast cancer. J. Mammary Gland Biol. Neoplasia 8, 335-345 (Pubitemid 39137515)
19. Espina, V., Wulfkuhle, J., and Liotta, L. A. (2009) Application of laser microdissection and reverse-phase protein microarrays to the molecular profiling of cancer signal pathway networks in the tissue microenvironment. Clin. Lab. Med. 29, 1-13
20. Ma, X. J., Dahiya, S., Richardson, E., Erlander, M., and Sgroi, D. C. (2009) Gene expression profiling of the tumor microenvironment during breast cancer progression. Breast Cancer Res. 11, R7
21. Nesvizhskii, A. I., Keller, A., Kolker, E., and Aebersold, R. (2003) A statistical model for identifying proteins by tandem mass spectrometry. Anal. Chem. 75, 4646-4658 (Pubitemid 37082259)
22. Sotiriou, C., Wirapati, P., Loi, S., Harris, A., Fox, S., Smeds, J., Nordgren, H., Farmer, P., Praz, V., Haibe-Kains, B., Desmedt, C., Larsimont, D., Cardoso, F., Peterse, H., Nuyten, D., Buyse, M., Van de Vijver, M. J., Bergh, J., Piccart, M., and Delorenzi, M. (2006) Gene expression profiling in breast cancer: Understanding the molecular basis of histologic grade to improve prognosis. J. Natl. Cancer Inst. 98, 262-272 (Pubitemid 43264710)
23. Ivshina, A. V., George, J., Senko, O., Mow, B., Putti, T. C., Smeds, J., Lindahl, T., Pawitan, Y., Hall, P., Nordgren, H., Wong, J. E., Liu, E. T., Bergh, J., Kuznetsov, V. A., and Miller, L. D. (2006) Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer. Cancer Res. 66, 10292-10301 (Pubitemid 44799747)
24. Wang, Y., Klijn, J. G., Zhang, Y., Sieuwerts, A. M., Look, M. P., Yang, F., Talantov, D., Timmermans, M., Meijer-van Gelder, M. E., Yu, J., Jatkoe, T., Berns, E. M., Atkins, D., and Foekens, J. A. (2005) Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 365, 671-679 (Pubitemid 40260888)
25. van de Vijver, M. J., He, Y. D., van't Veer, L. J., Dai, H., Hart, A. A., Voskuil, D. W., Schreiber, G. J., Peterse, J. L., Roberts, C., Marton, M. J., Parrish, M., Atsma, D., Witteveen, A., Glas, A., Delahaye, L., van der Velde, T., Bartelink, H., Rodenhuis, S., Rutgers, E. T., Friend, S. H., and Bernards, R. (2002) A gene-expression signature as a predictor of survival in breast cancer. N. Engl. J. Med. 347, 1999-2009 (Pubitemid 35461656)
26. Chin, K., DeVries, S., Fridlyand, J., Spellman, P. T., Roydasgupta, R., Kuo, W. L., Lapuk, A., Neve, R. M., Qian, Z., Ryder, T., Chen, F., Feiler, H., Tokuyasu, T., Kingsley, C., Dairkee, S., Meng, Z., Chew, K., Pinkel, D., Jain, A., Ljung, B. M., Esserman, L., Albertson, D. G., Waldman, F. M., and Gray, J. W. (2006) Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. Cancer Cell 10, 529-541 (Pubitemid 44854748)
27. Dai, M., Wang, P., Boyd, A. D., Kostov, G., Athey, B., Jones, E. G., Bunney, W. E., Myers, R. M., Speed, T. P., Akil, H., Watson, S. J., and Meng, F. (2005) Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data. Nucleic Acids Res. 33, e175
28. Storey, J. D., and Tibshirani, R. (2003) Statistical significance for genome-wide studies. Proc. Natl. Acad. Sci. U.S.A. 100, 9440-9445
29. Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., and Mesirov, J. P. (2005) Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. U.S.A. 102, 15545-15550 (Pubitemid 41528093)
30. Bateman, N. W., Sun, M., Hood, B. L., Flint, M. S., and Conrads, T. P. (2010) Defining central themes in breast cancer biology by differential proteomics: Conserved regulation of cell spreading and focal adhesion kinase. J. Proteome Res. 9, 5311-5324
31. Zhu, W., Fang, C., Gramatikoff, K., Niemeyer, C. C., and Smith, J. W. (2011) Proteins and an inflammatory network expressed in colon tumors. J. Proteome Res. 10, 2129-2139
32. Szklarczyk, D., Franceschini, A., Kuhn, M., Simonovic, M., Roth, A., Minguez, P., Doerks, T., Stark, M., Muller, J., Bork, P., Jensen, L. J., and von Mering, C. (2011) The STRING database in 2011: Functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res. 39, D561-D568
33. Elkon, R., Vesterman, R., Amit, N., Ulitsky, I., Zohar, I., Weisz, M., Mass, G., Orlev, N., Sternberg, G., Blekhman, R., Assa, J., Shiloh, Y., and Shamir, R. (2008) SPIKE: A database, visualization and analysis tool of cellular signaling pathways. BMC Bioinformatics 9, 110
34. Ideker, T., Ozier, O., Schwikowski, B., and Siegel, A. F. (2002) Discovering regulatory and signalling circuits in molecular interaction networks. Bioinformatics 18, (Suppl. 1) S233-S240 (Pubitemid 41185658)
35. Komurov, K., White, M. A., and Ram, P. T. (2010) Use of data-biased random walks on graphs for the retrieval of context-specific networks from genomic data. PLoS Comput. Biol. 6, e1000889
36. Dittrich, M. T., Klau, G. W., Rosenwald, A., Dandekar, T., and Müller, T. (2008) Identifying functional modules in protein-protein interaction networks: An integrated exact approach. Bioinformatics 24, i223-i231 (Pubitemid 351911677)
37. Wirapati, P., Sotiriou, C., Kunkel, S., Farmer, P., Pradervand, S., Haibe-Kains, B., Desmedt, C., Ignatiadis, M., Sengstag, T., Schütz, F., Goldstein, D. R., Piccart, M., and Delorenzi, M. (2008) Meta-analysis of gene expression profiles in breast cancer: Toward a unified understanding of breast cancer subtyping and prognosis signatures. Breast Cancer Res. 10, R65
38. Haibe-Kains, B., Desmedt, C., Piette, F., Buyse, M., Cardoso, F., Van't Veer, L., Piccart, M., Bontempi, G., and Sotiriou, C. (2008) Comparison of prognostic gene expression signatures for breast cancer. BMC Genomics 9, 394
39. Reis-Filho, J. S., Weigelt, B., Fumagalli, D., and Sotiriou, C. (2010) Molecular profiling: Moving away from tumor philately. Sci. Transl. Med. 2, 47ps43
40. Wagner, E. F., and Nebreda, A. R. (2009) Signal integration by JNK and p38 MAPK pathways in cancer development. Nat. Rev. Cancer 9, 537-549
41. Pham, C. G., Bubici, C., Zazzeroni, F., Papa, S., Jones, J., Alvarez, K., Jayawardena, S., De Smaele, E., Cong, R., Beaumont, C., Torti, F. M., Torti, S. V., and Franzoso, G. (2004) Ferritin heavy chain upregulation by NF-κB inhibits TNFα-induced apoptosis by suppressing reactive oxygen species. Cell 119, 529-542 (Pubitemid 39482352)
42. Zhang, K. H., Tian, H. Y., Gao, X., Lei, W. W., Hu, Y., Wang, D. M., Pan, X. C., Yu, M. L., Xu, G. J., Zhao, F. K., and Song, J. G. (2009) Ferritin heavy chain-mediated iron homeostasis and subsequent increased reactive oxygen species production are essential for epithelial-mesenchymal transition. Cancer Res. 69, 5340-5348
43. Antosiewicz, J., Ziolkowski, W., Kaczor, J. J., and Herman-Antosiewicz, A. (2007) Tumor necrosis factor-α-induced reactive oxygen species formation is mediated by JNK1-dependent ferritin degradation and elevation of labile iron pool. Free Radic. Biol. Med. 43, 265-270 (Pubitemid 46977169)
44. Pantopoulos, K. (2004) Iron metabolism and the IRE/IRP regulatory system: An update. Ann. N.Y. Acad. Sci. 1012, 1-13
45. Sherman, M., and Multhoff, G. (2007) Heat shock proteins in cancer. Ann. N.Y. Acad. Sci. 1113, 192-201 (Pubitemid 350015025)
46. Ciocca, D. R., and Calderwood, S. K. (2005) Heat shock proteins in cancer: Diagnostic, prognostic, predictive, and treatment implications. Cell Stress Chaperones 10, 86-103 (Pubitemid 40942470)
47. Ciocca, D. R., Oesterreich, S., Chamness, G. C., McGuire, W. L., and Fuqua, S. A. (1993) Biological and clinical implications of heat shock protein 27,000 (Hsp27): A review. J. Natl. Cancer Inst. 85, 1558-1570 (Pubitemid 23304684)
48. De, A. K., Kodys, K. M., Yeh, B. S., and Miller-Graziano, C. (2000) Exaggerated human monocyte IL-10 concomitant to minimal TNF-α induction by heat-shock protein 27 (Hsp27) suggests Hsp27 is primarily an anti-inflammatory stimulus. J. Immunol. 165, 3951-3958 (Pubitemid 32057304)
49. Lee, Y. J., Lee, D. H., Cho, C. K., Chung, H. Y., Bae, S., Jhon, G. J., Soh, J. W., Jeoung, D. I., Lee, S. J., and Lee, Y. S. (2005) HSP25 inhibits radiation-induced apoptosis through reduction of PKCδ-mediated ROS production. Oncogene 24, 3715-3725 (Pubitemid 40826871)
50. Rousseau, S., Dolado, I., Beardmore, V., Shpiro, N., Marquez, R., Nebreda, A. R., Arthur, J. S., Case, L. M., Tessier-Lavigne, M., Gaestel, M., Cuenda, A., and Cohen, P. (2006) CXCL12 and C5a trigger cell migration via a PAK1/2-p38α MAPK-MAPKAP-K2-HSP27 pathway. Cell. Signal. 18, 1897-1905 (Pubitemid 44485980)
51. Garrido, C., Bruey, J. M., Fromentin, A., Hammann, A., Arrigo, A. P., and Solary, E. (1999) HSP27 inhibits cytochrome c-dependent activation of procaspase-9. FASEB J. 13, 2061-2070 (Pubitemid 29517636)
52. Rouleau, M., Patel, A., Hendzel, M. J., Kaufmann, S. H., and Poirier, G. G. (2010) PARP inhibition: PARP1 and beyond. Nat. Rev. Cancer 10, 293-301
53. David, K. K., Andrabi, S. A., Dawson, T. M., and Dawson, V. L. (2009) Parthanatos, a messenger of death. Front. Biosci. 14, 1116-1128
54. Meng, F., Zhang, H., Liu, G., Kreike, B., Chen, W., Sethi, S., Miller, F. R., and Wu, G. (2011) p38γ mitogen-activated protein kinase contributes to oncogenic properties maintenance and resistance to poly(ADP-ribose)- polymerase-1 inhibition in breast cancer. Neoplasia 13, 472-482
55. Turner, N. C., Lord, C. J., Iorns, E., Brough, R., Swift, S., Elliott, R., Rayter, S., Tutt, A. N., and Ashworth, A. (2008) A synthetic lethal siRNA screen identifying genes mediating sensitivity to a PARP inhibitor. EMBO J. 27, 1368-1377 (Pubitemid 351655175)
56. Hannun, Y. A. (1996) Functions of ceramide in coordinating cellular responses to stress. Science 274, 1855-1859
57. Pyne, N. J., and Pyne, S. (2010) Sphingosine 1-phosphate and cancer. Nat. Rev. Cancer 10, 489-503
58. Cuvillier, O., Pirianov, G., Kleuser, B., Vanek, P. G., Coso, O. A., Gutkind, S., and Spiegel, S. (1996) Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature 381, 800-803 (Pubitemid 26243122)
59. Strelow, A., Bernardo, K., Adam-Klages, S., Linke, T., Sandhoff, K., Krönke, M., and Adam, D. (2000) Overexpression of acid ceramidase protects from tumor necrosis factor-induced cell death. J. Exp. Med. 192, 601-612
60. Vander Heiden, M. G., Cantley, L. C., and Thompson, C. B. (2009) Understanding the Warburg effect: The metabolic requirements of cell proliferation. Science 324, 1029-1033
61. Hatzivassiliou, G., Zhao, F., Bauer, D. E., Andreadis, C., Shaw, A. N., Dhanak, D., Hingorani, S. R., Tuveson, D. A., and Thompson, C. B. (2005) ATP citrate lyase inhibition can suppress tumor cell growth. Cancer Cell 8, 311-321 (Pubitemid 41443416)
62. Wellen, K. E., Hatzivassiliou, G., Sachdeva, U. M., Bui, T. V., Cross, J. R., and Thompson, C. B. (2009) ATP-citrate lyase links cellular metabolism to histone acetylation. Science 324, 1076-1080
63. Wagner, P. D., Steeg, P. S., and Vu, N. D. (1997) Two-component kinase-like activity of nm23 correlates with its motility-suppressing activity. Proc. Natl. Acad. Sci. U.S.A. 94, 9000-9005
64. Boissan, M., De Wever, O., Lizarraga, F., Wendum, D., Poincloux, R., Chignard, N., Desbois-Mouthon, C., Dufour, S., Nawrocki-Raby, B., Birembaut, P., Bracke, M., Chavrier, P., Gespach, C., and Lacombe, M. L. (2010) Implication of metastasis suppressor NM23-H1 in maintaining adherens junctions and limiting the invasive potential of human cancer cells. Cancer Res. 70, 7710-7722
65. Otsuki, Y., Tanaka, M., Yoshii, S., Kawazoe, N., Nakaya, K., and Sugimura, H. (2001) Tumor metastasis suppressor nm23H1 regulates Rac1 GTPase by interaction with Tiam1. Proc. Natl. Acad. Sci. U.S.A. 98, 4385-4390 (Pubitemid 32294986)
66. Santra, M., Eichstetter, I., and Iozzo, R. V. (2000) An anti-oncogenic role for decorin. Down-regulation of ErbB2 leads to growth suppression and cytodifferentiation of mammary carcinoma cells. J. Biol. Chem. 275, 35153-35161
67. Egeblad, M., and Werb, Z. (2002) New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer 2, 161-174 (Pubitemid 37328786)
68. Bissell, M. J., Radisky, D. C., Rizki, A., Weaver, V. M., and Petersen, O. W. (2002) The organizing principle: Microenvironmental influences in the normal and malignant breast. Differentiation 70, 537-546 (Pubitemid 36194318)
69. Ehnis, T., Dieterich, W., Bauer, M., Kresse, H., and Schuppan, D. (1997) Localization of a binding site for the proteoglycan decorin on collagen XIV (undulin). J. Biol. Chem. 272, 20414-20419 (Pubitemid 27355593)
70. Reed, C. C., Waterhouse, A., Kirby, S., Kay, P., Owens, R. T., McQuillan, D. J., and Iozzo, R. V. (2005) Decorin prevents metastatic spreading of breast cancer. Oncogene 24, 1104-1110 (Pubitemid 40313888)
71. Araki, K., Wakabayashi, H., Shintani, K., Morikawa, J., Matsumine, A., Kusuzaki, K., Sudo, A., and Uchida, A. (2009) Decorin suppresses bone metastasis in a breast cancer cell line. Oncology 77, 92-99
72. Goldoni, S., Seidler, D. G., Heath, J., Fassan, M., Baffa, R., Thakur, M. L., Owens, R. T., McQuillan, D. J., and Iozzo, R. V. (2008) An antimetastatic role for decorin in breast cancer. Am. J. Pathol. 173, 844-855
73. Troup, S., Njue, C., Kliewer, E. V., Parisien, M., Roskelley, C., Chakravarti, S., Roughley, P. J., Murphy, L. C., and Watson, P. H. (2003) Reduced expression of the small leucine-rich proteoglycans, lumican, and decorin is associated with poor outcome in node-negative invasive breast cancer. Clin. Cancer Res. 9, 207-214 (Pubitemid 36109735)